Research Article | Open Access
Abdiryim Yusup, Halmurat Upur, Anwar Umar, Benedicte Berke, Nicholas Moore, "Ethanol Extract of Abnormal Savda Munziq, a Herbal Preparation of Traditional Uighur Medicine, Inhibits Caco-2 Cells Proliferation via Cell Cycle Arrest and Apoptosis", Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 926329, 6 pages, 2012. https://doi.org/10.1155/2012/926329
Ethanol Extract of Abnormal Savda Munziq, a Herbal Preparation of Traditional Uighur Medicine, Inhibits Caco-2 Cells Proliferation via Cell Cycle Arrest and Apoptosis
Aims. Study the effect of Abnormal Savda Munziq (ASMq) ethanol extract on the proliferation, apoptosis, and correlative gene, expression in colon cancer cells (Caco-2) to elucidate the molecular mechanisms responsible for the anticancer property of Abnormal Savda Munziq. Materials and Methods. ASMq ethanol extract was prepared by a professional pharmacist. Caco-2 cells were treated with different concentration of ASMq ethanol extract (0.5–7.5 mg/mL) for different time intervals (48 and 72 h). Antiproliferative effect of ASMq ethanol extract was determined by MTT assay; DNA fragmentation was determined by gel electrophoresis assay; cell cycle analysis was detected by flow cytometer; apoptosis-related gene expression was detected by RT-PCR assay. Results. ASMq ethanol extract possesses an inhibition effect on Caco-2 cells proliferation, induction of cell apoptosis, cell cycle arrest in sub-G1 phase, and downregulation of bcl-2 and upregulation of Bax gene expression. Conclusion. The anticancer mechanism of ASMq ethanol extract may be involved in antiproliferation, induction of apoptosis, cell cycle arrest, and regulation of apoptosis-related gene expression such as bcl-2 and Bax activity pathway.
Cancer is the second leading cause of death worldwide. Cancer continues to represent the largest cause of mortality in the world. China is confronted with an increasing incidence of cancer and cancer deaths annually. Mortality that results from the common forms of cancer will be unacceptably high in the 21th century. Despite many therapeutic advances in the understanding of the processes in carcinogenesis, overall mortality statistics are unlikely to change until there is a reorientation of the concepts for the use of natural products as new chemopreventive agents [1–4].
Natural products include thousands of compounds that exist in fruits, vegetables, plants, and herbs, and several clinical anticancer drugs have been derived from natural products. Thus, development of compounds with anticancer effects from natural products has currently become a very important topic. Natural compounds isolated from medicinal plants, as rich sources of novel anticancer drugs, have been of increasing interest since then [5, 6]. Cancer prevention and treatment using traditional Chinese medicines have also attracted increasing interest, and the development of pharmacology and molecular biology makes it possible to screen effective extracts with anticancer activity from the Traditional Uighur medicinal herbs and many relevant prescriptions.
Traditional Uighur Medicine, the main part of Traditional Chinese Medicine, has been used for pharmaceutical and dietary therapy for several millennia. Traditional Uighur medicine has its own traditional theory for prevention and treatment of cancer with prescriptions containing Abnormal Savda Munziq (ASMq) . To date, the anticancer effects of ASMq and its potential mechanism of action have been studied on HepG2 cells, Hela cells, T lymphoma cells, and breast cancer cells. Furthermore, the total flavonoids of ASMq were proved to be the most important anticancer-active ingredients of ASMq . In the present study, we used human colon cancer cells (Caco-2) to examine the anticancer effects of ASMq ethanol extract to assess the potential effect of Abnormal Savda Munziq (ASMq) ethanol extract on colon carcinogenesis.
2. Materials and Methods
Dulbecco’s modified eagle medium (DMEM), RPMI1640, foetal calf serum (FCS), ethylenediamine tetraacetic acid (EDTA), ribonuclease A (RNase A), proteinase K, ethidium bromide, N-Lauroyl sarcosine, propidium iodide, trypsine-0.02% EDTA mixture were obtained from Sigma-Aldrich (Lyon, France). SV Total RNA Isolation System, Reverse Transcription System, dNTPs Mixture, Taq DNA polymerase, BenchTop 1kb DNA Ladder, DNA loading buffer were all from Promega, France. Oligonucleotides used in PCR were from Eurogentec S.A, Britsh. All other chemicals used were of analytical grade.
2.2. Preparation of ASMq Ethanol Extract
ASMq is composed of 10 kinds of herbs . Herbs used in this study were obtained from Xinjiang Hospital of Traditional Uighur Medicine (Urumqi, China). High quality herbs were selected by a specialist, mixed according to the relevant recipe, and the ethanol extract was prepared by a professional pharmacist . In average, the yield of ethanol extract was 12.0% (w/w) from ASMq. ASMq ethanol extract used in the experiments was dissolved in distilled water as a 100 mg/mL (w/v) stock solution and sterilized by 0.45 μm Millipore filter unit for experimental use. The stock solution was further diluted with cell culture medium (DMEM) for cell culture and treatment.
2.3. Cell Culture and Treatment
Caco-2 cells, a human colon cancer cell line, were obtained from the American Type Culture Collection (ATCC) and were grown in a high glucose concentration (4.5 g/L) DMEM medium supplemented with 10% FCS, 1% L-glutamine (200 mM), and 1% penicillin-streptomycin (100 IU–100 μg/mL) in a humidified atmosphere of 5% CO2-95% air mixture at 37°C. All data presented in this report were obtained at least from three independent experiments.
2.4. Cell Viability Assay
The viability of the cells was assessed by MTT (3,4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide) assay, which is based on the reduction of MTT by the mitochondrial dehydrogenase of intact cells to a purple formazan product . Cells (2.5 × 104) were plated in a 96-well plate (Coastar from Corning, NY) and routinely incubated for 24 h at 37°C prior to use. After 24 h they were treated with different concentrations (0.5–7.5 mg/mL) of ASMq ethanol extract for different time intervals (48 and 72 h). After the treatment, media containing ASMq ethanol extract were carefully removed by aspiration. 100 μL of 0.5 mg/mL MTT in cell culture medium was added to each well and incubated for 2 h. 100 μL of 10% SDS, 0.01 M HCl solution was added to each well to dissolve the formazon crystals formed. The plates were covered with aluminum foil and kept in an incubator for 12 h for dissolution of the formed formazan crystals. Amount of formazan was determined measuring the absorbance at 560 nm using a microplate reader.
2.5. DNA Fragmentation Detection
The cells were cultured (5 × 106 cells per mL) in 25 cm2 flasks, total volume 5 mL of medium per flask, in the presence of ASMq ethanol extract (0.5–7.5 mg/mL) for different time intervals (24 and 48 h) at 37°C. Controls were performed at the same time with DMEM. After incubation for 24 h, the cell layer was rinsed twice with 5 mL of PBS. To extract DNA, the cells were lysed by incubation for 5 min with 1 mL of lysis buffer (1% N-Lauroyl sarcosine, 20 mM Tris-HCl pH 8.0, 5 mM EDTA), and the cell lysates were collected and transferred into 15 mL corning tubes. Proteins were digested overnight by incubation with 100 μg/mL proteinase K at 37°C, then 7.5 M ammonium acetate and phenol-tris (pH 8)-chloroform (2 : 1, v/v) were added to the homogenate. After centrifugation for 5 min at 2200 ×g at 10°C, one volume of SEVAG (3 mL) was added to the aqueous supernatant and the mixture was centrifuged for 5 min at 2200 ×g at 10°C. The aqueous supernatant was transferred to Eppendorf tubes and incubated for 5 min at 37°C to eliminate traces of chloroform. RNA was digested by incubation with 12 μg/mL RNase A for 30 min at 37°C, and then one volume of SEVAG was added. After centrifugation for 5 min at 2200 ×g at 10°C, the DNA in the aqueous supernatant was precipitated at −10°C for 4 h with ethanol. The mixture was centrifuged for 45 min at 2200 ×g at 4°C, and the supernatant removed. The pellet was rinsed with 70% ethanol, dried at room temperature for 2 h, and resuspended in 200 μL of TE 20–1 (20 mM Tris-HCl pH 8.0, 1 mM EDTA) for DNA quantification by UV spectrophotometry at 254 nm. Loading buffer was added to 10 μg of DNA for each treatment, and the samples were analysed by electrophoresis on a 1% agarose gel (1.5 h at 80 V/30 mA) with a TBE running buffer (44 mM Tris–HCl, 44 mM boric acid, 50 mM EDTA, pH 8.0) .
2.6. Cell Cycle Analysis by Flow Cytometry
For cell cycle analysis, 5 × 105 cells seeded in 3 mL total volume in 6-well multidishes were incubated as described above for 48 h. Flow cytometric analyses were conducted using a FACScan (Becton Dickinson, France). At the end of incubation, the cells were rinsed twice with PBS and trypsinized in trypsine-0.02% EDTA mixture. After centrifugation for 10 min at 600 ×g at 4°C, the supernatant was removed, the pellet resuspended in 300 μL of PBS, then 700 μL of cold methanol were added and the mixture kept at −20°C for 30 min. After centrifugation for 5 min at 600 ×g and at 4°C, the pellet was treated with 2 mg/mL RNase A at 37°C during 30 min and stained with 50 μg/mL propidium iodide containing 0.1% Triton X-100 and EDTA 0.02 mg/mL. The percentage of cells in each stage of the cell cycle was determined by counting 104 cells, using cellquest software (Becton Dickinson, France) .
2.7. Gene Expression Studies
Expression of apoptosis-related genes, bcl-2, bax, p21, and p53, was studied using reverse transcriptase-PCR (RT-PCR). 5 × 105 cells seeded in 3 mL total volume in 6-well multidishes were incubated with the presence of ASMq ethanol extract (0.5–7.5 mg/mL) for 48 h at 37°C. The housekeeping genes GAPDH were used as control. At the end of incubation, the cells were rinsed twice with PBS and trypsinized in trypsine-0.02% EDTA mixture. After centrifugation for 5 min at 500 ×g at 4°C, the supernatant was removed, and the pellet was used for RT-PCR studies. Total RNA was isolated using SV Total RNA Isolation System (Promega, France). cDNA was generated by Reverse Transcription System (Promega, France). 10 μL of cDNA product was used for PCR reaction as templates. PCR was carried out using the gene-specific upstream and downstream primers (Table 1). Initial denaturation at 95°C for 3 min was followed by a PCR cycle of denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C for 2 min. PCR products were separated on a 1.5% agarose gel and stained with ethidium bromide .
2.8. Statistical Analysis
The data are expressed as mean ± standard deviation (SD) for at least three independent determinations in triplicate or quadruplicated for each experimental point. The statistical differences between treated groups and control groups were determined by Student’s t-test, and was statistically significant difference.
3.1. Inhibition of Cell Growth
Caco-2 cells were used as a model system to examine the effect of ASMq ethanol extract on their growth. The growth inhibitory effect of ASMq ethanol extract was concentration and time dependent (Figure 1). The IC50 at 48 and 72 h was 5.99 mg/mL and 3.02 mg/mL, respectively.
3.2. Induction of DNA Fragmentation
Results showed that Caco-2 cells treated with ASMq ethanol extract did not induce any DNA fragmentation at the concentration of 0.5–2.5 mg/mL at 48 h of incubation. In contrast, the apoptotic fragments were clearly detected when the cells were treated with a higher concentration of ASMq ethanol extract, 5.0 and 7.5 mg/mL, for 48 h (Figure 2). These observations exhibited that ASMq ethanol extract-induced Caco-2 cells death was possibly mediated through an apoptotic pathway.
3.3. Cell Cycle Analysis by Flow Cytometry
Flow cytometry analysis performed on Caco-2 cells after 48 h of incubation with ASMq ethanol extract (0.5–7.5 mg/mL) indicated an alteration in the percentage of cells in each stage of the cell cycle: G0/G1, S and G2/M, as compared to the control (Table 2). We observed at concentrations higher than 5.0 mg/mL an increase in the number of cells in the sub-G1 phase and a decrease in the G0/G1 phase as compared to the control cells (). However, the percentage of cells in the S-phase and G2/M phase remained unchanged as compared to the controls (). On the other hand, as shown in Figure 3, the sub-G1 peak was detected in a concentration-dependent manner. These results suggested that ASMq ethanol extract had a prominent ability to induce apoptosis in Caco-2 cells.
|, as compared with control culture Representative data from three individual analyses.|
3.4. Expression of Apoptotic Genes
As the results shown in Figure 4, the gene expression of Bax increased and the expression of Bcl-2 decreased concentration dependently in Caco-2 cells after ASMq ethanol extracts treatment for 48 h. But there were not any changes in the expressions of p53 and p21 genes. This indicated that the induction of apoptosis with ASMq ethanol treatment was at least related to the regulation of Bax and Bcl-2 expression, but no relation to the expression of p53 and p21 genes.
Cancer causes significant morbidity and mortality and is a major public health problem worldwide. An effective cancer prevention program, diet, herb and exercise may decrease the incidence of cancer. Herbs, herbal formulations, and herb-derived compounds are known to have curative potential [3, 6, 12–15]. Abnormal Savda Munziq (ASMq) is a herbal formulation used for cancers in traditional Uighur Medicine and its anticancer activity is well documented [7, 16]. Aqueous extract, ethanol extract, ethyl acetate extract, and total flavonoids of ASMq have been reported to possess inhibitory effect towards a broad range of cancer cells in vitro [8, 9, 17–19], and ASMq ethanol extract had chemoprotective effects on DMH-induced colon carcinogenesis . The acting ingredients in ASMq that exerted the anticancer effect may include polyphenols such as flavanoids, which are abundant in ASMq ethanol extract . The molecular mechanism underlying the ASMq ethanol extract induced apoptosis in HepG2 cells has been reported to be associated with increase of caspase-3 activity, DNA fragmentation and Bax/Bcl-2 dependent pathway [9, 19].
Apoptosis, also called the programmed cell death characterized by several morphological and biochemical events, is now known as an important type of cell death in response to cytotoxic treatment. It is a general physiological process to remove unwanted cells without damaging the neighboring cells and inducing inflammatory responses. In recent years, many studies have demonstrated that the dysregulation of apoptosis process is involved in the development of neoplastic transformation and tumor growth. The induction of apoptosis in tumor cells has been shown to be the most common anticancer mechanism conjoint by many cancer therapies. Thus, to find the potential therapeutic antitumor drugs with potent and selective apoptotic effect would be valuable. The administration of many natural compounds with anticancer effect has been shown to be capable of inducing the apoptotic death of cancer cells [21–24].
In the present study, we found that ASMq ethanol extract displayed a significant inhibitory effect on the proliferation of Caco-2 cell lines in a dose and time dependently manner. Furthermore, a high-concentration of ASMq ethanol extract (more than 5.0 mg/mL) resulted in significant induction of apoptosis in Caco-2 cells, as evidenced by DNA fragmentation and sub-G1 peak of apoptotic markers detection. More interestingly, the Caco-2 cells treated with ASMq ethanol extract in the concentration of 7.5 mg/mL for 48 h exhibited a dramatic accumulation of cells in sub-G1 phase (13.56%).
Many genes such as p53, p21, and genes in Bcl-2 family have been demonstrated to play important roles in deciding the initiation and execution of apoptosis in tumor cells exposed to radiation or anticancer drugs. It has been demonstrated that Bcl-2 family members, such as Bcl-2 itself and Bax, are mediators of apoptosis . The balance of proapoptotic Bax and antiapoptotic Bcl-2 is known to be important in determining whether cells die or survive. Bax/Bcl-2 ratio in a cell acts to regulate its own susceptibility to apoptosis . In the present study, to clarify the molecular mechanism of apoptosis mediated by ASMq ethanol extract, we examined the expression of genes including p53, p21, Bax, and Bcl-2 by RT-PCR. Our studies indicated that ASMq ethanol extract-induced apoptosis in Caco-2 cells accompanied by the dose-dependent down-regulation of Bcl-2 gene expression and upregulation of Bax gene expression, while p53 and p21 were not significantly changed.
The present study suggested that the anticancer effect of ASMq ethanol extract was mediated through multiple pathways. ASMq ethanol extract inhibits cell growth and induces DNA fragmentation and apoptosis in a concentration-dependent manner. Induction of apoptosis is possibly related with Bcl-2 and Bax dependent pathway, but independent of p53 and p21 gene expression. In addition, as a herbal medicine, ASMq ethanol extract has its unique properties of low cost, easy oral consumption, and a long history of use by the Uighur population, all of which are indicative of its potential application as an anticancer agent.
This research was supported by the Program for New Century Excellent Talents in University (NCET), Ministry of Education of the People’s Republic of China and by a research grant from Science and Technology Department of Xinjiang Uighur Autonomous Region, China (no. 200733146-4).
- J. Bradbury, “From Chinese medicine to anticancer drugs,” Drug Discovery Today, vol. 10, no. 17, pp. 1131–1132, 2005.
- R. Han, “Recent progress in the study of anticancer drugs originating from plants and traditional medicine in China,” Chinese Medical Journal, vol. 108, no. 10, pp. 729–731, 1995.
- K. H. Lee, “Anticancer drug design based on plant-derived natural products,” Journal of Biomedical Science, vol. 6, no. 4, pp. 236–250, 1999.
- J. M. Pezzuto, “Plant-derived anticancer agents,” Biochemical Pharmacology, vol. 53, no. 2, pp. 121–133, 1997.
- M. Shoemaker, B. Hamilton, S. H. Dairkee, I. Cohen, and M. J. Campbell, “In vitro anticancer activity of twelve Chinese medicinal herbs,” Phytotherapy Research, vol. 19, no. 7, pp. 649–651, 2005.
- J. Sun, B. R. Liu, W. J. Hu, L. X. Yu, and X. P. Qian, “In vitro anticancer activity of aqueous extracts and ethanol extracts of fifteen traditional Chinese medicines on human digestive tumor cell lines,” Phytotherapy Research, vol. 21, no. 11, pp. 1102–1104, 2007.
- H. Upur and A. Yusup, Theory of Mizaj and Hilit in Uighur Medicine and Modern Study, Science and Technology Press, Urumqi, China, 2003.
- A. Yusup, H. Upur, X. Tursun, B. Berke, I. Baudrimont, and N. Moore, “Study on mechanism of abnormal Savda Munziq flavonoids in induction of apoptosis of Hep2 cells,” Zhongguo Zhong Yao Za Zhi, vol. 32, no. 11, pp. 1068–1071, 2007.
- H. Upur, A. Yusup, I. Baudrimont et al., “Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine,” Evidence-Based Complementary and Alternative Medicine. In press.
- S. Abid-Essefi, I. Baudrimont, W. Hassen et al., “DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK, Vero and Caco-2 cells: Prevention by Vitamin E,” Toxicology, vol. 192, no. 2-3, pp. 237–248, 2003.
- S. T. Huang, R. C. Yang, L. J. Yang, P. N. Lee, and J. H. Pang, “Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells,” Life Sciences, vol. 72, no. 15, pp. 1705–1716, 2003.
- J. Ma, K. A. Reed, and J. M. Gallo, “Cells designed to deliver anticancer drugs by apoptosis,” Cancer Research, vol. 62, no. 5, pp. 1382–1387, 2002.
- C. Kanadaswami, L. T. Lee, P. P. Lee et al., “The antitumor activities of flavonoids,” In Vivo, vol. 19, no. 5, pp. 895–910, 2005.
- H. Ichikawa, Y. Nakamura, Y. Kashiwada, and B. B. Aggarwal, “Anticancer drugs designed by mother nature: ancient drugs but modern targets,” Current Pharmaceutical Design, vol. 13, no. 33, pp. 3400–3416, 2007.
- Y. Sun, K. Xun, Y. Wang, and X. Chen, “A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs,” Anti-Cancer Drugs, vol. 20, no. 9, pp. 757–769, 2009.
- H. Upur, A. Yusup, A. Umar, and N. Moore, “Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda,” Therapie, vol. 59, no. 4, pp. 483–484, 2004.
- A. Yusup, H. Upur, I. Baudrimont et al., “Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells,” Fundamental and Clinical Pharmacology, vol. 19, no. 4, pp. 465–472, 2005.
- A. Yusup, H. Upur, T. Kadir, I. Baudrimont, and N. Moore, “Effect of abnormal Savda Munziq ethyl acetate extract on the proliferation apoptosis and correlative gene expression in human hepatoma (HepG2) cells,” Journal of China Pharmaceutical University, vol. 37, no. 2, pp. 161–164, 2006.
- A. Yusup, H. Upur, T. Kadir, I. Baudrimont, and N. Moore, “Mechanism of abnormal Savda Munziq ethanol extract on HepG2 cell apoptosis,” Chinese Traditional Patent Medicine, vol. 28, no. 7, pp. 1005–1008, 2006.
- A. Yusup, H. Upur, A. Umar et al., “Abnormal Savda Munziq, an herbal preparation of traditional uighur medicine, may Prevent 1,2-dimethylhydrazine-induced rat colon carcinogenesis,” Evidence-Based Complementary and Alternative Medicine. In press.
- H. Tian, L. Ip, H. Luo, D. C. Chang, and K. Q. Luo, “A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine,” British Journal of Pharmacology, vol. 150, no. 3, pp. 321–334, 2007.
- V. Srivastava, A. S. Negi, J. K. Kumar, M. M. Gupta, and S. P. Khanuja, “Plant-based anticancer molecules: a chemical and biological profile of some important leads,” Bioorganic and Medicinal Chemistry, vol. 13, no. 21, pp. 5892–5908, 2005.
- S. M. Hadi, S. H. Bhat, A. S. Azmi, S. Hanif, U. Shamim, and M. F. Ullah, “Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties,” Seminars in Cancer Biology, vol. 17, no. 5, pp. 370–376, 2007.
- C. R. Gardner, “Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism,” Expert Review of Anticancer Therapy, vol. 4, no. 6, pp. 1157–1177, 2004.
- S. J. Korsmeyer, J. R. Shutter, D. J. Veis, D. E. Merry, and Z. N. Oltvai, “Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death,” Seminars in Cancer Biology, vol. 4, no. 6, pp. 327–332, 1993.
Copyright © 2012 Abdiryim Yusup et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.